Utilization of a Telephone Quitline by Smokeless Tobacco Users Lowell C. Dale, MD Associate Professor of Medicine College of Medicine, Mayo Clinic Medical.

Slides:



Advertisements
Similar presentations
Results Introduction Tobacco use is the leading preventable cause of death in Wisconsin and the United States. Given the risk of smoking initiation during.
Advertisements

Intervention and Promotion Makes a Difference Tobacco cessation intervention by healthcare providers improves quit rates. Brief counseling is all that.
RESEARCH OVERVIEW Traci Rieckmann, Ph.D. OREGON HEALTH AND SCIENCES UNIVERSITY DOUG NOVINS, M.D., UNIVERSITY OF COLORADO DENVER LAURIE MOORE, M.P.H. UNIVERSITY.
Vance Rabius, PhD Pamela Villars, MEd, LPC K Joanne Pike, MA, LPC Alfred McAlister, PhD Dawn Wiatrek, PhD Presented to the 2007 National Conference on.
Treatment of Tobacco Dependence in 2012 J. Taylor Hays, MD Professor of Medicine Associate Director Nicotine Dependence Center Mayo Clinic Rochester, MN.
Socioeconomic Status and Smoking in Canada, : Has there been any progress on disparities in tobacco use? Jessica Reid, David Hammond, Pete Driezen.
Concurrent Tobacco Use: A Study of Socio-demographic Correlates Nasir Mushtaq, MPH Laura A Beebe, PhD University of Oklahoma Health Sciences Center.
Program Highlights, Highlights,Evaluation & Surveillance
1 The Impact of Smoking in Los Angeles County March 25, 2010 Jonathan Fielding, M.D., M.P.H., M.B.A Director of Public Health and Health Officer L.A. County.
Through With Chew Week.
Cotinine is an Unreliable Biomarker for Systemic Exposure in Spit Tobacco Users Jon O. Ebbert, MD, MSc Lowell C. Dale, MD Liza Nirelli Darrell Schroeder,
First RCT of Web-Based Acceptance & Commitment Therapy For Smoking Cessation: 3 Month Processes & Outcomes Jonathan B. Bricker, PhD Fred Hutchinson Cancer.
Smoking during Pregnancy in the Kalkaska county Kate Galloup Misty Donley Audrey Munn.
Smoking Cessation in the Military: Challenges, Solutions, And Issues for Women Smokers Robert C. Klesges, Ph.D. Professor, Department of Preventive Medicine,
Cannabis use and its socio- demographic correlates among in-school adolescents in Zambia Emmanuel Rudatsikira, MD, DrPH Dean & Professor School of Health.
Economics of Tobacco Use and Help-Seeking Behavior Bishwa Adhikari, Ph.D., Economist Office on Smoking and Health Centers for Disease Control and Prevention.
Epidemiology of smoking and quitting in Hungary Edit Paulik, László Nagymajtényi Department of Public Health, Faculty of Medicine, University of Szeged.
Journal Club Sidharth Bagga MD. Cytisus laborium L. (Golden rain acacia)
Demonstration of a Process- Outcome Link for Smoking Cessation Melissa M. Farmer, PhD 1,2 Elizabeth M. Yano, PhD 1,2 Brian S. Mittman, PhD 1,2 Scott E.
Real-world effectiveness of nicotine replacement therapy in pregnancy Leonie S. Brose, PhD Andy McEwen, PhD & Robert West, PhD University College London.
Roll-your-own smokers and quitting through the Quitline Judy Li, MSc Researcher The Quit Group.
Giving a way free stuff to motivate smokers to call a Quitline North American Quitline Consortium Meeting May 2, 2005.
Effect of Depression on Smoking Cessation Outcomes Sonne SC 1, Nunes EV 2, Jiang H 2, Gan W 2, Tyson C 1, Reid MS 3 1 Medical University of South Carolina,
Smoke-Free Homes & Smoking Cessation TUS-CPS overlap sample Karen Messer, Ph D Moores UCSD Cancer Center.
Introduction Smoking and Social Networks Joseph R. Pruis, Student Research Collaborator, Rosemary A. Jadack, PhD, RN, Professor Department Of Nursing,
Motivational Interviewing (MI) is effective and efficient for fostering health behavior change, and the elicitation of “change talk” (CT: i.e., any expression.
Group vs. individual therapy – which is best? Andy McEwen CRUK Health Behaviour Unit University College London.
EXPERIENCES OF SEXUAL VIOLENCE AMONG ADOLESCENTS IN BOTH URBAN AND RURAL KENYA The 8th Pan-African PCAF Psychotrauma Conference Victoria Mutiso, PhD, Senior.
Some thoughts about minimal dataset Róbert Urbán Smoking Cessation Center Budapest.
MINIMAL DATA SET FOR QUITLINES North American Quitline Consortium Annual Meeting May 2005 NORTH AMERICAN QUITLINE CONSORTIUM.
Nicotine Dependence: Comparing Menthol and Non-Menthol Cigarette Smokers Qiang Li, MS Andrew Hyland, PhD Gary Giovino, MS, PhD Joseph Bauer, PhD Michael.
Smoking Intervention in the Emergency Department Colleen Connor York College Biology Department Is smoking intervention in the emergency department achievable?
Mary Hrywna, MPH Cristine D. Delnevo, PhD, MPH Dorota Staniewska, MS University of Medicine & Dentistry of New Jersey (UMDNJ) School of Public Health (SPH)
The Usual Source of Care and Delivery of Preventive Services to Medicare Beneficiaries Academy Health, June 2005 Hoangmai Pham, MD, MPH Deborah Schrag,
F UNCTIONAL L IMITATIONS IN C ANCER S URVIVORS A MONG E LDERLY M EDICARE B ENEFICIARIES Prachi P. Chavan, MD, MPH Epidemiology PhD Student Xinhua Yu MD.
Factors associated with health care providers’ practice of smoking cessation interventions in public health facilities in Kiambu County, Kenya Dr Judy.
Predictors of study retention in addiction treatment trials KORTE JE 1, MAGRUDER KM 1,2, KILLEEN TK 1, SONNE SC 1, SAMPSON RR 1 and BRADY KT 1,2 1. Medical.
Are Prenatal Care Providers Following Best-Practice Guidelines for Addressing Pregnancy Smoking? Results from Northeast Tennessee Department of Family.
Hospital based smoking cessation service – more smokers quitting and staying smoke-free. Paula Campbell, Regional Officer – Smoking Prevention Ann O’Farrell,
Efficacy of Combination First Line Agents for Smoking Cessation Sneha Baxi, Pharm.D. Pharmacy Practice Resident University of Illinois at Chicago.
PHQ-9 Severity and Screening Tests Predictive of Remission Outcomes at Six Months Kurt B. Angstman, MS MD Associate Professor John M. Wilkinson Assistant.
1 University College London February 2014 Robert West Population impact of tobacco dependence treatment.
I removed the quit attempt variable from the adjusted model. I removed the quit attempt variable from the adjusted model.e Sarah Kowitt, MPH 1 ; Tanha.
Motivation to Quit Smoking Among Relatives of Lung Cancer Patients Ellen J. Hahn, DNS, RN Mary Kay Rayens, PhD Jennifer Hatcher, RN, PhD Mei Zhang, MPH,
Medication Adherence and Substance Abuse Predict 18-Month Recidivism among Mental Health Jail Diversion Program Clients Elizabeth N. Burris 1, Evan M.
Society for Prevention Research 21st Annual Meeting (May 28-31, 2013) in San Francisco, CA A. Fogarasi-Grenczer 1, I. Rákóczi 2, K. L. Foley PhD. 3, P.
Clare Meernik, MPH 1 ; Anna McCullough, MSW, MSPH, CTTS 1 ; Leah Ranney, PhD 1 ; Barbara Walsh 2 ; Adam O. Goldstein, MD, MPH 1 Predictors of Quit for.
Barbara Silver, MA, CTTS, Carol Ripley-Moffitt, MDiv, CTTS, Jillian E. Harris, BASW, Mark Gwynne, MD, Adam Goldstein, MD, MPH Nicotine Dependence Program.
1 How best to motivate and help smokers to stop University College London November 2010 Robert West.
A Randomised Controlled Trial of Nicotine Replacement Therapy for Low-Income Smokers Valerie Sedivy, Caroline Miller and Jacqueline Hickling.
Full Circle: A Holistic Cessation Intervention Serving American Indians in Oklahoma Sally Carter, MSW, Oklahoma State Department of Health; Cynthia Tainpeah,
The Impact of Smoking Cessation Interventions by Multiple Health Professionals Lawrence An, MD 1 ; Steven Foldes, PhD 2 ; Nina Alesci, PhD 1 ; Patricia.
Correlates of Never Using Condoms for Oral Sex Sara K. Head, MPH 1 Richard A. Crosby, PhD 1 Gregory Moore, MD 1 Adewale Troutman, MD 2 1 University of.
Generalized Logit Model
1University of Kentucky, Lexington, Kentucky
Predictors of study retention in drug abuse treatment trials
Paula Gardiner MD MPH Boston University Medical School
Jonathan Foulds, Jessica M. Yingst, Susan Veldheer, Shari Hrabovsky,
Disparities in process and outcome measures among adults with persistent asthma David M. Mosen, PhD, MPH; Michael Schatz, MD, MS; Rachel Gold, PhD; Winston.
DECLARATION OF POTENTIAL CONFLICT OF INTEREST
How stages of change can predict screening and brief intervention outcome for alcohol problems in young adult emergency department patients.
Georges J. Nahhas, PhD, MPH Postdoctoral Scholar
Lung Cancer Screening: Do Individual Health Beliefs Matter?
Improving the Lives of Callers: Call Outcomes and Unmet Needs
Trends in electronic cigarette use in England
Alcohol, Other Drugs, and Health: Current Evidence May-June, 2018
Pritaporn Kingkaew, B.Pharm, MSc (Health Economics), PhD candidate
Alcohol, Other Drugs, and Health: Current Evidence March–April 2018
Trends in electronic cigarette use in England
Helping younger smokers quit:
Presentation transcript:

Utilization of a Telephone Quitline by Smokeless Tobacco Users Lowell C. Dale, MD Associate Professor of Medicine College of Medicine, Mayo Clinic Medical Director, Mayo Clinic Tobacco Quitline Rochester, MN

Prevalence (2004) 7.2 million Americans used ST 7.2 million Americans used ST 4.9% of young adults (18-25 yo) past month use 4.9% of young adults (18-25 yo) past month use 6.2% of Males 6.2% of Males 0.5% of Females 0.5% of Females Results from the 2004 National Survey on Drug Use and Health: National Findings

Prevalence ST use is higher in rural areas than in urban areas ST use is higher in rural areas than in urban areas 8.0% Rural counties 8.0% Rural counties 1.7% Large metropolitan areas 1.7% Large metropolitan areas Differs by geographic area Differs by geographic area 4.1% South (highest) 4.1% South (highest) 1.5% Northeast (lowest) 1.5% Northeast (lowest) 2.2 % College graduates 3.7% High school completer/non-completers 2.2 % College graduates 3.7% High school completer/non-completers 2004 National Survey on Drug Use and Health

Health Effects: Cancers - U.S. Data Location OR (95% CI) Location OR (95% CI) Cancer, Mouth and Gum 11.2 ( ) A Cancer, Mouth and Gum 11.2 ( ) A Gum & Buccal Mucosa 4.2 ( ) B Gum & Buccal Mucosa 4.2 ( ) B Larynx 7.3 ( ) A Larynx 7.3 ( ) A Salivary gland 5.3 ( ) A Salivary gland 5.3 ( ) A Kidney cancer 4.0 ( ) C Kidney cancer 4.0 ( ) C Pancreatic cancer 3.5 ( ) D Pancreatic cancer 3.5 ( ) D A - Stockwell HG, et al. Head Neck Surg Nov-Dec;9(2): B - Winn DM, et al. N Engl J Med Mar 26;304(13): C - Goodman MT, et al. Am J Epidemiol Dec;124(6): D - Alguacil J, et al. Cancer Epidemiol Biomarkers Prev Jan;13(1):55-8.

Background Intervention programs—including telephone quitlines—have focused primarily on cigarette smokers. We describe Mayo Clinic Tobacco Quitline’s experience with a subpopulation of smokeless tobacco users who called for assistance in stopping their Smokeless Tobacco (ST) use.

Mayo Clinic Tobacco Quitline (MCTQ) Established 1998 by Mayo Clinic NDC Established 1998 by Mayo Clinic NDC Moved to Mayo Health Companies (MMSI) in 2000 Moved to Mayo Health Companies (MMSI) in 2000 Protocols jointly developed with NDC Protocols jointly developed with NDC Counseling staff of MCTQ trained by NDC personnel Counseling staff of MCTQ trained by NDC personnel Clinical oversight provided by NDC Clinical oversight provided by NDC Protocols and materials specifically designed for smokeless tobacco users Protocols and materials specifically designed for smokeless tobacco users minute assessment and development of a treatment plan minute assessment and development of a treatment plan Up to four, minute proactive follow-up calls timed around quit date and first 3 months after initial assessment Up to four, minute proactive follow-up calls timed around quit date and first 3 months after initial assessment

Methods: Subject Selection 4586 callers who enrolled in MCTQ intervention program 1/1/06-11/30/06 Only their first enrollment (if more than one) Only their first enrollment (if more than one) Seven-month outcome data was collected by MCTQ (vs. an external evaluator) Seven-month outcome data was collected by MCTQ (vs. an external evaluator) Were eligible for the seven-month outcome call Were eligible for the seven-month outcome call Reported only use of smokeless tobacco = 173 Reported only use of smokeless tobacco = 173 Males reported smoking cigarettes exclusively Males reported smoking cigarettes exclusively = 1774

Methods Telephone outcome call at 7 months after initial contact, by trained caller (not counselor) from the MCTQ Telephone outcome call at 7 months after initial contact, by trained caller (not counselor) from the MCTQ Abstinence outcome measure: self-reported, 30-day all-tobacco abstinence at seven months Abstinence outcome measure: self-reported, 30-day all-tobacco abstinence at seven months All those who could not be reached after several attempts were considered using tobacco (intention-to-treat) All those who could not be reached after several attempts were considered using tobacco (intention-to-treat) Demographic characteristics as predictors of abstinence were each assessed uni-variately using logistic regression. Age and cans/week were treated as continuous variables, all others treated as categorical variables Demographic characteristics as predictors of abstinence were each assessed uni-variately using logistic regression. Age and cans/week were treated as continuous variables, all others treated as categorical variables

Baseline Characteristics (1) Characteristic Smokeless (N=173) Cigarettes (N=1774) P-value Age: mean ± SD 40.5 ± ± Age:<.001 ≤ 35 ≤ 3532%32% %36% ≥ 51 ≥ 5115%32% Sex Male 98%100% Race<.001 Caucasian Caucasian98%88% Other Other2%12%

Baseline Characteristics (2) Characteristic Smokeless (N=173) Cigarettes (N=1774) P-value Education<.001 ≤ High school ≤ High school34%46% Some college Some college25%28% ≥College degree ≥College degree42%25% Income<.001 <$50,000 <$50,00038%59% 50, ,00046%30% >100,000 >100,00017%11% State client 52%73%<.001

Baseline Characteristics (3) Characteristic Smokeless (N=173) Cigarettes (N=1774) P-value Cans/week 4.1 ± 3.4 ≤ 3 ≤ 352% % ≥ 8 ≥ 86% Cigarettes/day 22.3 ± % % >40 >4013%

Utilization and Outcomes Smokeless (N=173) Cigarettes (N=1774) P-value* Number of follow-up calls 0.19 Mean ± SD 2.6 ± ± 1.8 Median (min, max) 3 (0,6) 2 (0,11) Outcome<.001 Abstinent50%31% Using ST/smoking 50%69% *p-values calculated using one-way ANOVA for continuous variables, chi-square for categorical

Predictors of Abstinence Smokeless Tobacco Users (N=173) CharacteristicP-value Cans/week ≤3 (57%) ≤3 (57%) 4-7 (45%) 4-7 (45%) ≥ 8 (20%) ≥ 8 (20%)0.02 Age.394 Sex.984 Education.510 Corporate* vs. State.196 Race.962 Income*.302 Time to 1 st Use*.644 Years of Use.737 Stop Confidence*.581 * Predicted abstinence in cigarette smokers + cpd

Summary Smokeless tobacco users were different from male cigarette smokers: Smokeless tobacco users were different from male cigarette smokers: Caucasian Caucasian Younger Younger Higher education Higher education Higher income Higher income Smokeless tobacco users, once engaged, used the Quitline services more than male smokers Smokeless tobacco users, once engaged, used the Quitline services more than male smokers Quit rates are high Quit rates are high Only amount of tobacco use predicted abstinence Only amount of tobacco use predicted abstinence

Conclusions IF we can expect tobacco abstinence rates to be as good as, if not better, than cigarette smokers when using a telephonic intervention specifically tailored to ST users IF we can expect tobacco abstinence rates to be as good as, if not better, than cigarette smokers when using a telephonic intervention specifically tailored to ST users THEN smokeless tobacco users should be targeted by Quitline promotions, especially in those states where the prevalence of smokeless tobacco use is high THEN smokeless tobacco users should be targeted by Quitline promotions, especially in those states where the prevalence of smokeless tobacco use is high AND treated appropriately AND treated appropriately

Authors Lowell C. Dale, MD 1,2 Lowell C. Dale, MD 1,2 Barbara Kreinbring, RN 1,2 Barbara Kreinbring, RN 1,2 Darrell Schroeder, MS 3 Darrell Schroeder, MS 3 Nathaniel Warner 3 Nathaniel Warner 3 Christopher Kasper 2 Christopher Kasper 2 1 Mayo Clinic Tobacco Quitline 2 Mayo Clinic Health Solutions 3 Division of Biostatics, Mayo Clinic